Optimized Trials: Propelling Research Forward With Healthcare-First Sites

The clinical research landscape is undergoing a transformation with the growing adoption of patient-centered and decentralized trials. Currently, nearly 40% of clinical trials incorporate decentralized elements, reflecting a broader trend towards optimizing patient comfort and accessibility. This shift highlights the emergence of "optimized trials," which are designed to enhance the research experience for both patients and sponsors.

Optimized trials focus on virtual-first models that simplify patient access to clinical research while streamlining the enrollment and retention processes for sponsors. By leveraging established physician-patient relationships through Elligo’s Healthcare-First site network, these trials improve the efficiency of research and patient engagement.

Elligo’s PatientSelect® solution facilitates this transition by offering centralized site management and increased patient diversity, thereby enhancing the overall research process. Discover how optimized trials can revolutionize your research strategy by contacting our experts today.